We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Genes Increase Risk of Obesity but Also Protect Against Disease
News

Genes Increase Risk of Obesity but Also Protect Against Disease

Genes Increase Risk of Obesity but Also Protect Against Disease
News

Genes Increase Risk of Obesity but Also Protect Against Disease

Credit: PublicDomainPictures/ Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genes Increase Risk of Obesity but Also Protect Against Disease"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

People living with obesity tend to have unhealthy glucose and lipid levels in their blood, as well as high blood pressure. As a result, they are more at risk of cardiovascular and metabolic diseases. But scientists have observed that up to 45% of people living with obesity have healthy blood pressure and glucose and lipid levels, and therefore may not be at high risk of disease. The reason why this group of people with obesity remain healthy, has been poorly understood.

But now a team of researchers - led by scientists at the University of Copenhagen and Icahn School of Medicine at Mount Sinai, New York - have identified a range of genes that are linked to both elevated levels of body fat, as well as offering protection from some of the negative health impacts of obesity. The results were published in the journal Nature Metabolism.

Associate Professor Tuomas Kilpeläinen from the Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR) at the University of Copenhagen says the findings shed new light on the biology that may disconnect higher level of body fat from higher risk of diabetes and heart disease.

"The identified genes seem to benefit our health by helping to maintain a healthy fat tissue. Some of the genes may offer targets for the development of new therapies that lower the risk of diabetes and heart disease by improving the health of our fat tissue," says Tuomas Kilpeläinen.

The scientists made the discovery by analyzing data from hundreds of thousands people who had been assessed for their body fat and disease risk markers. They identified 62 sections of the genome that were significantly associated with both high levels of body fat and lower risk of cardiometabolic diseases. Further analyses showed that the genes had a range of functions in the body, including the regulation and development of fat cells, distribution of body fat, as well as energy regulation and inflammation.

Staff Scientist Lam Opal Huang from CBMR carried out the computational analyses that identified the genes.

"We used a data-driven approach in this study, which led us to find new genes associated with fat tissue health, instead of the known obesity genes associated with central nervous system, which control satiety and are typically linked to unhealthy obesity," says Lam Opal Huang.

According to Professor Ruth Loos from the Icahn School of Medicine at Mount Sinai, this new knowledge is a step toward a more nuanced approach to treating obesity.

"Clearly, obesity is a complex disease and not every individual with excess body weight is equally at risk of developing cardiometabolic diseases. Knowing which genes protect people from developing diabetes and cardiovascular disease will eventually help us better diagnose and treat individuals with obesity."

Reference: Huang LO, Rauch A, Mazzaferro E, et al. Genome-wide discovery of genetic loci that uncouple excess adiposity from its comorbidities. Nat. Metab. 2021;3(2):228-243. doi: 10.1038/s42255-021-00346-2

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement